Reinach, Switzerland 9/2/14; Reinach, Switzerland 9/18/14; Jena, Germany 9/18/14—Analytik Jena has announced that it plans to delist from the Frankfurt Stock Exchange’s Prime Standard segment. Over-the-counter listings on the Stuttgart, Munich, Hanover, Düsseldorf, Berlin and Hamburg exchange will be not be affected. The company stated that it expects to reduce administrative costs as a result […]
Cambridge, UK 9/29/14—Horizon Discovery, a provider of gene-editing technology and services, has agreed to acquire Sage Labs for $48 million in cash and stock. Sage is a supplier of advanced in vivo transgenic disease models for use in preclinical research. Sage generated nine-month revenues of $4.7 million. Horizon stated that the acquisition diversifies its product […]
Washington, DC 9/17/14—In a filing with the SEC, VWR has set an IPO price of $22–$25 per share (see IBO 6/30/14) and will offer 25,532,000 shares of common stock on the NASDAQ stock exchange. At the midpoint of the price range, the company expects to raise approximately $561.0 million. Following the offering, current majority-owners Madison […]
Santa Clara, CA 9/17/14; Santa Clara, CA 9/17/14; Santa Clara, CA 9/17/14—Agilent Technologies has announced that Mike McMullen, senior vice president and president of the Chemical Analysis Group (CAG), will succeed William Sullivan as CEO on March 18, 2015. Agilent has appointed Mr. McMullen president and COO, effective immediately. “Agilent’s re-launch is the perfect time […]
Darmstadt, Germany and St. Louis, MO 9/22/14—Pharmaceutical and chemical company Merck KGaA has agreed to acquire Sigma-Aldrich, a life science and technology firm, for $140 per share in cash, or approximately $17 billion. The price represents a 37% premium to Sigma’s September 19 closing stock price. The companies offer a complementary range of products including […]
London, UK 9/9/14; Cambridge, UK 9/9/14—Abcam, a publicly held provider of protein-research tools and services, announced the appointment of Alan Hirzel as CEO, effective immediately. He replaces Jonathan Milner, PhD, who will now serve as deputy chairman. Mr. Hirzel previously served as chief marketing officer. “Alan will take over the leadership of the company, with […]
San Diego, CA 9/2/14—BioLegend acquired on August 29 the Antibody Services business unit of Covance for an undisclosed amount. The business develops and manufactures antibodies and research reagents for neuroscience, immunopathology, cell biology, epitope tags and immunohistochemistry detection, including IVD antibodies for immunohistochemistry (IHC). “The addition of Neuroscience and IHC antibody tools to our catalog […]
Yokohama, Japan 9/9/14—Publicly held Japanese iPSC firm ReproCELL has acquired the iPS Cell Business Unit of Stemgent for an undisclosed amount. The Business Unit supplies iPSC-research reagent products, including mRNA reprogramming kits, xeno-free culture media and specialty chemicals for cell differentiation. ReproCELL stated that the acquisition would broaden its selection of iPSC products and strengthen […]
Radnor, PA 9/10/14—VWR has acquired Netherlands- and Belgium-based Klinipath and its affiliates Immunologic, Mortupath and Klinipath BVBA for an undisclosed amount. Kilinipath provides equipment, consumables and reagents, representing suppliers for the histology, pathology, cytology, immunology and clinical chemistry industries, as well as supplies private-label equipment, reagents and plastic disposables. “Klinipath, Immunologic and Mortupath are recognized […]
Washington, DC 9/2/14—Danaher has implemented its succession plan (see IBO 4/30/14) ahead of schedule, appointing Thomas P. Joyce, Jr. as president and CEO, effective September 9. “The transition has proceeded quite well since April, and the Board has concluded that Tom is now ready to be Chief Executive Officer,” commented Steven M. Rales, chairman of […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
